Predictive Factors of Intracranial Response of Immune Checkpoint Inhibitors in Patients with Brain Metastasis from Non-Small Cell Lung Cancer

Autor: Julien Bermudez, Mohamed Boucekine, Céline Mascaux, Laurent Greillier, Fabrice Barlesi, Julie Biemar, Y. Trigui, Pascale Tomasini

Publikováno v: Journal of Cancer Therapy. 10:692-707

Background: Immune checkpoint inhibitors (ICI)s were recently approved for the treatment of advanced non-small cell lung cancer (NSCLC). Whereas brain metastases (BM) are frequent in NSCLC patients, data are missing regarding ICIs intracranial effica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a4dde7d20776a5d87ec31a67ef4adec
https://doi.org/10.4236/jct.2019.108057

Respiratory impairment in Niemann-Pick B disease: Two case reports and review for the pulmonologist

Autor: Pascal Chanez, B. Puech, Martine Reynaud-Gaubert, Thibaut Capron, Y. Trigui, Clarisse Gautier

Publikováno v: Respiratory Medicine and Research
Respiratory Medicine and Research, 2019, 76, pp.13-18. ⟨10.1016/j.resmer.2019.05.001⟩
Respiratory Medicine and Research, Elsevier, 2019, 76, pp.13-18. ⟨10.1016/j.resmer.2019.05.001⟩

Acid sphingomyelinase deficiency (ASMD), also called Niemann-Pick disease, is a storage disorder with pulmonary involvement but few respiratory symptoms in adults. However, the disease may evolve towards clinically relevant respiratory symptoms with

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bf8314d58c27443be3f9d3f0aba62d9
https://hal-amu.archives-ouvertes.fr/hal-02509328

Effet du décubitus ventral vigile sur l’augmentation du support ventilatoire des patients atteints d’une pneumonie hypoxémiante à COVID-19 : étude de cohorte rétrospective

Autor: S. Lehingue, J.M. Forel, Anne Marie Dols, M. Gaune, Pascal Chanez, L. Lefebvre, A. Loundou, E. Prud’homme, X. Elharrar, Laurent Papazian, Y. Trigui, A. Boyer

Publikováno v: Revue des Maladies Respiratoires Actualités. 13:111

Introduction Le COVID-19 peut entrainer un syndrome de detresse respiratoire aigue (SDRA). Chez les patients intubes atteints de SDRA severe, des seances precoces, prolongees et repetees de decubitus ventral (DV) reduisent la mortalite. Le DV vigile

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::322d3e239459a7783d9d9b6dd48bbc6f
https://doi.org/10.1016/j.rmra.2020.11.230

Association Between Immune-related Adverse Events and Efficacy of Immune Checkpoint Inhibitors in Non-small-cell Lung Cancer

Autor: Pascale Tomasini, Arnaud Jeanson, Fabrice Barlesi, M. Grangeon, N. Khobta, S. Chaleat, M. Souquet-Bressand, J. Bermudez, Y. Trigui, C. Mascaux, Marilyne Blanchon, Laurent Greillier, Mohamed Boucekine

Publikováno v: Clinical lung cancer. 20(3)

Immune checkpoint inhibitors (ICIs) are available for first- and further lines of treatment of patients with advanced non-small-cell lung cancer (NSCLC). These treatments are associated with adverse events called immune-related adverse events (IRAEs)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13a145c5ec7fb0736fd2f4a994e171d
https://pubmed.ncbi.nlm.nih.gov/30442524

Interactions entre immunothérapie et radiothérapie dans le traitement du cancer bronchopulmonaire non à petites cellules, efficacité et tolérance

Autor: Mohamed Boucekine, S. Chaleat, Laurent Greillier, M. Grangeon, M. Souquet-Bressand, J. Bermudez, Arnaud Jeanson, S. Jourdan, Fabrice Barlesi, Y. Trigui, C. Mascaux, Pascale Tomasini

Publikováno v: Revue des Maladies Respiratoires. 35:A63-A64

Introduction L’immunotherapie a une place grandissante dans le traitement du cancer bronchique non a petites cellules (CBNPC). Des etudes precliniques suggerent une augmentation des effets secondaires, ainsi qu’une augmentation d’efficacite (ef

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::deba02140f8b400a3391ac73115fa3c3
https://doi.org/10.1016/j.rmr.2017.10.130